TechSelect determines the commercialization potential of lifescience technologies. Often a company, lifescience accelerator or even a university has numerous technologies that it is incubating, and the executive staff needs to determine which technologies have the highest probability to deliver the greatest return on investment. It can be challenging for executives to decide when the technologies include medical devices, biologics or a range of pharmaceutical compounds for a broad array of clinical indications, and this is especially true when many are at different stages of development. How does the executive staff know where to allocate their scarce patenting dollars?
Click above for an example of TechSelect Commercial Interest vs Technology Rating
TechSelect is a cost effective analysis that delivers objective direction about which technologies are projected to deliver the greatest rewards to the institution and the researcher. It is a collaborative process that includes interviews, peer reviewed literature analysis, competitive and market analysis, all woven together with business threads. Based on the combined backgrounds and experience of the Strategy Inc. team and more than 15 years of performing business due diligence on compelling lifescience technology on a global basis, we are able to deliver a quantitative comparison revealing: Which technologies are going to be the biggest hits.
Click above for a Technology Development Timeline example
TechSelect includes projects the following;
- Clinical adoption of a device, pharmaceutical, combination product or biologic
- Commercial interest in the technology at different stages of development
- Competitive advantages of the technologies evaluated
- Drivers and barriers to technology adoption to determine the challenges and their influence
- Projected commercialization risk based on technology evaluation
- Anticipated technology development time to commercialization
Click above for a Drivers and Barriers to Adoption example
